We are live on
!
Find out more
WCM
Weld Capital Management Portfolio holdings
AUM
$98.8M
1-Year Est. Return
52.83%
This Fund
S&P 500
This Quarter
Est. Return
+31.95%
1 Year Est. Return
+52.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$58.8M
(+30%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
10.69%
Top 10 Holdings %
Top 10 Hldgs %
8.39%
Holding
719
New
321
Increased
57
Reduced
70
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.86M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$2.35M |
| 3 |
Voya Financial
VOYA
|
+$2.1M |
| 4 |
Idacorp
IDA
|
+$2.03M |
| 5 |
Cardinal Health
CAH
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.11M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$1.99M |
| 3 |
Lam Research
LRCX
|
+$1.92M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.84M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.35% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Technology | 12.47% |
| 4 | Financials | 12.13% |
| 5 | Industrials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
301
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $277K | 0.11% |
22,756
-21,684
| -49% | -$251K |
|
|
PRO
302
DELISTED
PROS Holdings
PRO
| $276K | 0.11% |
+6,213
| New | +$219K |
|
303
Progyny
PGNY
$2.44B
| $274K | 0.11% |
+10,618
| New | +$244K |
|
304
Universal Electronics
UEIC
$57.8M
| $273K | 0.11% |
+5,831
| New | +$245K |
|
|
STL
305
DELISTED
Sterling Bancorp
STL
| $273K | 0.11% |
+23,293
| New | +$267K |
|
306
Codexis
CDXS
$151M
| $271K | 0.11% |
+23,810
| New | +$269K |
|
307
Archer Daniels Midland
ADM
$38.2B
| $270K | 0.11% |
6,755
-1,512
| -18% | -$56.6K |
|
308
Editas Medicine
EDIT
$396M
| $270K | 0.11% |
+9,116
| New | +$238K |
|
|
CLVS
309
DELISTED
Clovis Oncology, Inc.
CLVS
| $269K | 0.11% |
+39,866
| New | +$302K |
|
310
AudioCodes
AUDC
$244M
| $265K | 0.1% |
+8,344
| New | +$256K |
|
311
Park Hotels & Resorts
PK
$3.03B
| $264K | 0.1% |
+26,664
| New | +$248K |
|
312
Ameresco
AMRC
$1.12B
| $263K | 0.1% |
9,479
-1,942
| -17% | -$39.1K |
|
313
IMAX
IMAX
$2.62B
| $263K | 0.1% |
23,424
+10,151
| +76% | +$119K |
|
314
Itaú Unibanco
ITUB
$93.2B
| $263K | 0.1% |
+76,978
| New | +$250K |
|
315
Elevance Health
ELV
$81.5B
| $261K | 0.1% |
+994
| New | +$265K |
|
316
Semtech
SMTC
$11B
| $260K | 0.1% |
+4,988
| New | +$233K |
|
317
Gaming and Leisure Properties
GLPI
$12.7B
| $259K | 0.1% |
+7,482
| New | +$233K |
|
318
Methanex
MEOH
$4.3B
| $259K | 0.1% |
+14,350
| New | +$238K |
|
319
CoreCivic
CXW
$2.96B
| $257K | 0.1% |
27,508
+9,366
| +52% | +$107K |
|
320
Integer Holdings
ITGR
$4.12B
| $254K | 0.1% |
+3,475
| New | +$253K |
|
321
Cimpress
CMPR
$2.39B
| $253K | 0.1% |
+3,320
| New | +$236K |
|
322
D.R. Horton
DHI
$40B
| $253K | 0.1% |
4,559
-3,187
| -41% | -$154K |
|
323
Flowserve
FLS
$9.71B
| $253K | 0.1% |
+8,860
| New | +$236K |
|
324
Macerich
MAC
$7.33B
| $253K | 0.1% |
28,210
-73,724
| -72% | -$571K |
|
325
Matador Resources
MTDR
$6.2B
| $253K | 0.1% |
+29,769
| New | +$208K |
|
Similar funds
BCM
CCM
RGM
RC
TCM
AC
QVT
WFWM
Weld Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Weld Capital Management held 719 positions worth $255M, up 30% from $196M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Weld Capital Management deployed $27.3M of net new capital in Q2 2020, opening 321 new positions and adding to 57 existing holdings. Its largest new stake was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Lam Research, an estimated $1.92M trimmed.
- Weld Capital Management's largest Q2 2020 buy was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
- Weld Capital Management added most to GoDaddy in Q2 2020, an estimated $1.61M increase.
- Weld Capital Management's biggest Q2 2020 reduction was Lam Research, cutting an estimated $1.92M.
- Weld Capital Management fully exited Vertex Pharmaceuticals in Q2 2020, selling an estimated $2.11M.
- Weld Capital Management's ten largest holdings make up 8.4% of its $255M portfolio in Q2 2020.
- Weld Capital Management opened 321 new positions and closed 271 in Q2 2020.
- Weld Capital Management's portfolio value rose 30% quarter-over-quarter to $255M.
Based on Weld Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.